A culture of "neuromysticism" has arisen around medical marijuana, breeding confusion for patients and clinicians alike. The dearth of quality research on safety and efficacy is a significant contributor to the situation. Dr. Schatman talks about what we know, what we don't, and where cannabinoids may fit in the pain management armamentarium.
Did you enjoy this article?
Subscribe to the PAINWeek Newsletter
and get our latest articles and more direct to your inbox